CONCLUSIONS The use of 2nd generation DES was associated with similar efficacy profile and improvement in safety performance, with a marked reduction in MI occurrence. 
BACKGROUND Indication of side branch (SB) intervention after main vessel (MV) stenting is not established in coronary bifurcation lesions.
METHODS
In the Coronary Bifurcation Stenting II Registry, 2,897 patients undergoing percutaneous coronary intervention using drugeluting stents for bifurcation lesions with SB 2.3 mm were enrolled. We selected 2,017 patients treated with 1-stent technique or MV stenting first strategy. Patients undergoing SB intervention after MV stenting (SB intervention group, n¼929) were compared to those not after MV stenting (no-SB intervention group, n¼1,088) in terms of cardiac death or myocardial infarction (MI).
RESULTS During a median follow-up duration of 37 months, the cumulative rate of cardiac death or MI tended to occur less frequently in the SB intervention group than in the no-SB intervention group (1.8 % versus 2.9%; adjusted hazard ratio [HR] 0.56; 95% confidence interval [CI] 0.29 to 1.07; p¼0.08). There was significant interaction between SB intervention and SB stenosis after MV stenting (p for interaction <0.01). Of 1,077 patients with diameter stenosis of SB 50% after MV stenting, SB intervention was associated with a lower risk of cardiac death or MI (1.2% versus 4.2%; adjusted HR 0.22; 95% CI 0.09 to 0.52; p<0.01). However, among 940 patients with diameter stenosis of SB <50%, there was no significant difference in cardiac death or MI (3.5% versus 2.2%; adjusted HR 1.36; 95% CI 0.58 to 3.20; p¼0.48) between the two groups. 
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BACKGROUND It is unclear whether the routine follow up (FU) coronary angiography (CAG) regardless of patient's symptoms after successful percutaneous coronary intervention (PCI) with drug-eluting stents (DESs) in patients (pts) with multi-vessel disease (MVD) is beneficial or not.
METHODS The study population consisted of 642 consecutive MVD pts underwent PCI with unrestricted utilization of DESs from January 2004 to May 2011. Routine FU CAG was performed between 6 to 9 months following index PCI and was decided by individual physician's discretion. Rests of the pts were clinically followed and ischemic driven events were captured. Clinical events including mortality, myocardial infarction and clinically driven PCI before 9 months were excluded in both groups. Cumulative clinical outcomes up to 3 years were compared between the Routine CAG group (n¼374 pts) and the Clinical FU group (n¼ 268 pts). To adjust potential confounders, a propensity score matched (PSM) analysis was performed using the logistic regression model.
RESULTS After PSM analysis, 2 propensity-matched groups (193 pairs, n ¼ 386 pts, C-statistic¼0.744) were generated and the baseline characteristics of the two groups were balanced. At 3 years, the incidence of target lesion revascularization (TLR) and target vessel revascularization (TVR) and major adverse cardiac events (MACEs) was higher in the Routine CAG group than the control group (Table) .
CONCLUSIONS Despite the expected beneficial effects, routine FU CAG following index PCI with DESs in MVD pts was associated with higher incidence of repeat PCI including TLR and TVR and MACE up to 3 years. BACKGROUND Although percutaneous coronary intervention (PCI) of chronic total occlusion (CTO) lesions commonly require 'full metal jacket'(FMJ, stent length 60mm without gaps) procedure to cover full coronary artery lesions, long-term clinical outcomes after FMJ procedure in CTO lesions remain largely unknown.
METHODS From Asan Medical Center-CTO registry, 388 consecutive patients treated with FMJ procedure and 719 with non-FMJ procedure were identified. The primary endpoint was the incidence of major adverse cardiac events (MACE) defined as a composite of death, Q-wave myocardial infarction (MI), or target-vessel revascularization (TVR).
RESULTS During a median follow-up of 4.5-years, the cumulative incidence of all-death were not significantly different between patients who underwent FMJ and non-FMJ procedure (9.1% vs. 8.4%, P¼0.51). After adjusting confounders, there was no significant difference between patients who received FMJ and non-FMJ procedure for the risk of MACE. (Hazard ratio [HR] 1.19, 95% confidence interval [CI] 0.80-1.75, P¼0.39). The adjusted risk of death (HR 1.28, 95% CI 0.78-2.12, P ¼0.33), Q-wave MI (HR 0.93, 95% CI 0.30-2.89, P ¼0.90) and TVR (HR 1.22, P¼0.56) were similar between the two groups. The incidence of definite/probable stent thrombosis was comparable (1.6% vs.1.1%, P¼0.58) throughout the follow-up period.
CONCLUSIONS The 4.5-year clinical outcomes of patients after CTO-PCI with FMJ procedure were comparable from those with non-FMJ procedure. 4 Sendai Kousei Hospital, Sendai, Japan BACKGROUND The SYNTAX study showed significant improvement in the efficacy of PCI using 1st generation DES for unprotected left main coronary artery (LMCA) disease. It has been proposed that the 2nd generation DES will provide better PCI outcomes for LMCA compared with SYNTAX trial. In Japan, PCI was frequently conducted with the guidance of IVUS. These procedural characteristics may further contribute to the improvement of PCI outcomes for LMCA.
METHODS J-Lesson is a prospective, single arm, open study that enrolled 441 unprotected LMCA treated with everolimus eluting drug eluting stent (EES) at 54 institutes in Japan. SYNTAX score and quantitative coronary angiogram was evaluated by independent corelaboratory. Primary end point of the present study was major adverse cardio-cerebrovascular event (MACCE) and MACCEþTVF was secondary end point. It is scheduled to follow-up for 5 years.
RESULTS In baseline characteristics, 40.4 % was DM and 36.8 % of the subjects had a history of PCI. The history of MI, stroke and PAD was observed in 18%, 8.9%, and 7.5%, respectively. Subjects were subdivided according to SYNTAX score (Low<23 n¼202, Intermediate 23-32 n¼146, High>32 n¼81). Euroscore 3-5 was 45.4% and >6 was 24.9%. IVUS guided PCI was underwent in 97.5%. Number of stent/lesion was 1.3 and mean stent length was 29.3mm. Interim analysis of 373 pts (84.6%) demonstrated that MACCE rate at 2 year was 3.9% (2.1-5.75) and no difference among 3 different SYNTAX score group. MACCE was also not different according to EuroSCORE. MACCEþTLR at 2 year was significantly higher in SYNTAX high group compared with the other 2 groups (SYNTAX low 4.5%, intermediate 8.9%, high 19.8%) and did not differ among 3 groups. Complete follow-up data will be available at TCT 2015.
CONCLUSIONS The J-lesson registry demonstrated clinical outcomes of PCI for LMCA with the combination use of 2nd generation DES and IVUS. The present outcomes support the clinical efficacy of PCI for LMCA. In addition, SYNTAX score is useful tool to discriminate the future revascularization risk, but could not discriminate the MACCE risk.
